The global Veterinary Biological Vaccines market size is predicted to grow from US$ 5606 million in 2025 to US$ 8006 million in 2031; it is expected to grow at a CAGR of 6.1% from 2025 to 2031.

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system?s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.

According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly ?6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 551%.

Infinity Market Research newest research report, the ?Veterinary Biological Vaccines Industry Forecast? looks at past sales and reviews total world Veterinary Biological Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Biological Vaccines sales for 2025 through 2031. With Veterinary Biological Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Biological Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Veterinary Biological Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Biological Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Veterinary Biological Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Biological Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Biological Vaccines.

This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Biological Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Live Attenuated Vaccines
    Inactivated Vaccines
    Others

Segmentation by Application:

    Livestock
    Swine
    Chicken
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Merck
    Zoetis
    Boehringer Ingelheim
    Ceva
    CAHIC
    HVRI
    Yebio
    DHN
    WINSUN
    Elanco
    Virbac
    CAVAC
    Kyoto Biken Laboratories
    FATRO
    Vaksindo
    Bio-Labs
    Avimex Animal Health
    MEVAC
    Biovac
    Atafen
    Dyntec
    Ringpu Biology
    Jinyu Bio-technology
    Jinhe Biotechnology
    China Animal Husbandry Industry
    Wuhan Keqian Biology
    Pulike Biological Engineering
    Chengdu Kanghua Biological Products

Key Questions Addressed in this Report

What is the 10-year outlook for the global Veterinary Biological Vaccines market?
What factors are driving Veterinary Biological Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Biological Vaccines market opportunities vary by end market size?
How does Veterinary Biological Vaccines break out by Type, by Application?